{"id":"https://openalex.org/W3190665387","doi":"https://doi.org/10.3892/etm.2021.9774","title":"Cost\u2011effectiveness analysis of different sequences of osimertinib administration for epidermal growth factor receptor\u2011mutated non\u2011small\u2011cell lung cancer","display_name":"Cost\u2011effectiveness analysis of different sequences of osimertinib administration for epidermal growth factor receptor\u2011mutated non\u2011small\u2011cell lung cancer","publication_year":2021,"publication_date":"2021-02-10","ids":{"openalex":"https://openalex.org/W3190665387","doi":"https://doi.org/10.3892/etm.2021.9774","mag":"3190665387","pmid":"https://pubmed.ncbi.nlm.nih.gov/33732316","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7903425"},"language":"en","primary_location":{"id":"doi:10.3892/etm.2021.9774","doi":"https://doi.org/10.3892/etm.2021.9774","is_oa":true,"landing_page_url":"https://doi.org/10.3892/etm.2021.9774","pdf_url":"https://www.spandidos-publications.com/10.3892/etm.2021.9774/download","source":{"id":"https://openalex.org/S151424340","display_name":"Experimental and Therapeutic Medicine","issn_l":"1792-0981","issn":["1792-0981","1792-1015"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320412","host_organization_name":"Spandidos Publishing","host_organization_lineage":["https://openalex.org/P4310320412"],"host_organization_lineage_names":["Spandidos Publishing"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experimental and Therapeutic Medicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.spandidos-publications.com/10.3892/etm.2021.9774/download","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100639479","display_name":"Wenqian Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210125137","display_name":"First Hospital of Jilin University","ror":"https://ror.org/034haf133","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210125137"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Wenqian Li","raw_affiliation_strings":["Cancer Center, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Center, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China","institution_ids":["https://openalex.org/I4210125137"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100318537","display_name":"Lei Qian","orcid":"https://orcid.org/0000-0002-0153-2717","observed_orcids":["https://orcid.org/0000-0002-0153-2717"]},"institutions":[{"id":"https://openalex.org/I4210125137","display_name":"First Hospital of Jilin University","ror":"https://ror.org/034haf133","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210125137"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Lei Qian","raw_affiliation_strings":["Cancer Center, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Center, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China","institution_ids":["https://openalex.org/I4210125137"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100318325","display_name":"W\u011bi Li","orcid":"https://orcid.org/0000-0002-9522-4474","observed_orcids":["https://orcid.org/0000-0002-9522-4474","https://orcid.org/0000-0003-4136-3409","https://orcid.org/0009-0009-9141-6389"]},"institutions":[{"id":"https://openalex.org/I4210125137","display_name":"First Hospital of Jilin University","ror":"https://ror.org/034haf133","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210125137"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Wei Li","raw_affiliation_strings":["Cancer Center, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Center, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China","institution_ids":["https://openalex.org/I4210125137"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Xiao Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210125137","display_name":"First Hospital of Jilin University","ror":"https://ror.org/034haf133","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210125137"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xiao Chen","raw_affiliation_strings":["Cancer Center, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Center, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China","institution_ids":["https://openalex.org/I4210125137"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045582815","display_name":"Hua He","orcid":"https://orcid.org/0000-0003-0015-8396","observed_orcids":["https://orcid.org/0000-0003-0015-8396"]},"institutions":[{"id":"https://openalex.org/I4210125137","display_name":"First Hospital of Jilin University","ror":"https://ror.org/034haf133","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210125137"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Hua He","raw_affiliation_strings":["Cancer Center, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Center, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China","institution_ids":["https://openalex.org/I4210125137"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109414980","display_name":"Huimin Tian","orcid":"https://orcid.org/0009-0001-4603-501X","observed_orcids":["https://orcid.org/0009-0001-4603-501X"]},"institutions":[{"id":"https://openalex.org/I4210125137","display_name":"First Hospital of Jilin University","ror":"https://ror.org/034haf133","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210125137"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Huimin Tian","raw_affiliation_strings":["Cancer Center, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Center, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China","institution_ids":["https://openalex.org/I4210125137"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103171670","display_name":"Yuguang Zhao","orcid":"https://orcid.org/0000-0002-4430-7798","observed_orcids":["https://orcid.org/0000-0002-4430-7798"]},"institutions":[{"id":"https://openalex.org/I4210125137","display_name":"First Hospital of Jilin University","ror":"https://ror.org/034haf133","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210125137"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yuguang Zhao","raw_affiliation_strings":["Cancer Center, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Center, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China","institution_ids":["https://openalex.org/I4210125137"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100407847","display_name":"Xu Wang","orcid":"https://orcid.org/0000-0002-1364-6973","observed_orcids":["https://orcid.org/0000-0002-1364-6973"]},"institutions":[{"id":"https://openalex.org/I4210125137","display_name":"First Hospital of Jilin University","ror":"https://ror.org/034haf133","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210125137"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xu Wang","raw_affiliation_strings":["Cancer Center, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Center, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China","institution_ids":["https://openalex.org/I4210125137"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036233749","display_name":"Jiuwei Cui","orcid":"https://orcid.org/0000-0001-6496-7550","observed_orcids":["https://orcid.org/0000-0001-6496-7550","https://orcid.org/0000-0002-1664-9491"]},"institutions":[{"id":"https://openalex.org/I4210125137","display_name":"First Hospital of Jilin University","ror":"https://ror.org/034haf133","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210125137"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Jiuwei Cui","raw_affiliation_strings":["Cancer Center, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Center, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China","institution_ids":["https://openalex.org/I4210125137"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5036233749"],"corresponding_institution_ids":["https://openalex.org/I4210125137"],"apc_list":null,"apc_paid":null,"fwci":1.0699,"has_fulltext":true,"cited_by_count":11,"citation_normalized_percentile":{"value":0.81751914,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"21","issue":"4","first_page":"343","last_page":"343"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9092000126838684,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9092000126838684,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0885000005364418,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/osimertinib","display_name":"osimertinib","score":1.0},{"id":"https://openalex.org/keywords/egfr-mutant-non-small-cell-lung-cancer","display_name":"EGFR-mutant non-small cell lung cancer","score":0.972000002861023},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.9309999942779541},{"id":"https://openalex.org/keywords/egfr-tyrosine-kinase-inhibitors","display_name":"EGFR tyrosine kinase inhibitors","score":0.8840000033378601},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.7089999914169312},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.9010000228881836},{"id":"https://openalex.org/keywords/treatment-sequencing","display_name":"treatment sequencing","score":0.4819999933242798},{"id":"https://openalex.org/keywords/willingness-to-pay-threshold","display_name":"willingness-to-pay threshold","score":0.7429999709129333},{"id":"https://openalex.org/keywords/quality-adjusted-life-years","display_name":"quality-adjusted life years","score":0.7979999780654907},{"id":"https://openalex.org/keywords/drug-pricing","display_name":"drug pricing","score":0.5370000004768372},{"id":"https://openalex.org/keywords/china","display_name":"China","score":0.5799999833106995},{"id":"https://openalex.org/keywords/united-states","display_name":"United States","score":1.0}],"concepts":[{"id":"https://openalex.org/C2777626846","wikidata":"https://www.wikidata.org/wiki/Q21506464","display_name":"Osimertinib","level":5,"score":0.9244800806045532},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6246795058250427},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.548302948474884},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.525515079498291},{"id":"https://openalex.org/C3019080777","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost effectiveness","level":2,"score":0.51268470287323},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.4997978210449219},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4215604364871979},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.32927966117858887},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.1271969974040985},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.3892/etm.2021.9774","doi":"https://doi.org/10.3892/etm.2021.9774","is_oa":true,"landing_page_url":"https://doi.org/10.3892/etm.2021.9774","pdf_url":"https://www.spandidos-publications.com/10.3892/etm.2021.9774/download","source":{"id":"https://openalex.org/S151424340","display_name":"Experimental and Therapeutic Medicine","issn_l":"1792-0981","issn":["1792-0981","1792-1015"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320412","host_organization_name":"Spandidos Publishing","host_organization_lineage":["https://openalex.org/P4310320412"],"host_organization_lineage_names":["Spandidos Publishing"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experimental and Therapeutic Medicine","raw_type":"journal-article"},{"id":"pmid:33732316","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33732316","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experimental and therapeutic medicine","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7903425","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7903425/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Exp Ther Med","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.3892/etm.2021.9774","doi":"https://doi.org/10.3892/etm.2021.9774","is_oa":true,"landing_page_url":"https://doi.org/10.3892/etm.2021.9774","pdf_url":"https://www.spandidos-publications.com/10.3892/etm.2021.9774/download","source":{"id":"https://openalex.org/S151424340","display_name":"Experimental and Therapeutic Medicine","issn_l":"1792-0981","issn":["1792-0981","1792-1015"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320412","host_organization_name":"Spandidos Publishing","host_organization_lineage":["https://openalex.org/P4310320412"],"host_organization_lineage_names":["Spandidos Publishing"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experimental and Therapeutic Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3190665387.pdf","grobid_xml":"https://content.openalex.org/works/W3190665387.grobid-xml"},"referenced_works_count":48,"referenced_works":["https://openalex.org/W1480250795","https://openalex.org/W1974400937","https://openalex.org/W1975731597","https://openalex.org/W1977373411","https://openalex.org/W1995517770","https://openalex.org/W1996652550","https://openalex.org/W2010596067","https://openalex.org/W2022229528","https://openalex.org/W2032689844","https://openalex.org/W2047783753","https://openalex.org/W2068267496","https://openalex.org/W2094606482","https://openalex.org/W2099180737","https://openalex.org/W2158646284","https://openalex.org/W2163351155","https://openalex.org/W2280175247","https://openalex.org/W2287661693","https://openalex.org/W2296800272","https://openalex.org/W2339311613","https://openalex.org/W2536396512","https://openalex.org/W2559848194","https://openalex.org/W2560717039","https://openalex.org/W2563765333","https://openalex.org/W2565966733","https://openalex.org/W2566197782","https://openalex.org/W2570618306","https://openalex.org/W2591118779","https://openalex.org/W2607954371","https://openalex.org/W2626223149","https://openalex.org/W2739010860","https://openalex.org/W2747965175","https://openalex.org/W2752647255","https://openalex.org/W2765831845","https://openalex.org/W2765920214","https://openalex.org/W2770828094","https://openalex.org/W2772237551","https://openalex.org/W2776194348","https://openalex.org/W2781525129","https://openalex.org/W2783729838","https://openalex.org/W2784266300","https://openalex.org/W2784538417","https://openalex.org/W2787553551","https://openalex.org/W2790465248","https://openalex.org/W2790649727","https://openalex.org/W2805264144","https://openalex.org/W2893040167","https://openalex.org/W2976278991","https://openalex.org/W2979271184"],"related_works":["https://openalex.org/W2905354278","https://openalex.org/W4296392247","https://openalex.org/W2805264144","https://openalex.org/W2909200466","https://openalex.org/W2893040167","https://openalex.org/W7222967925","https://openalex.org/W4402006552","https://openalex.org/W3083667265","https://openalex.org/W2979480540","https://openalex.org/W6939340285"],"abstract_inverted_index":{"Osimertinib":[0],"is":[1,12,29],"a":[2,103,229,270],"third-generation":[3],"epidermal":[4],"growth":[5],"factor":[6],"receptor-tyrosine":[7],"kinase":[8],"inhibitor":[9],"(EGFR-TKI)":[10],"that":[11],"clinically":[13],"effective":[14],"in":[15,44,52,94,159,163,173,187,199,216,234,238,273],"patients":[16],"with":[17,73,102,178,185,201,225,255],"EGFR-mutated":[18],"non-small-cell":[19],"lung":[20],"cancer":[21],"(NSCLC).":[22],"However,":[23,263],"the":[24,47,53,64,81,110,125,142,164,169,174,188,212,239],"use":[25],"of":[26,38,41,83,107,141,157,197,205,214,232],"this":[27],"treatment":[28],"limited":[30],"by":[31],"its":[32],"high":[33],"cost.":[34],"A":[35],"cost-effectiveness":[36,154,204],"analysis":[37,87,210],"different":[39,90,217],"sequences":[40],"osimertinib":[42,70,79,132,176,190,193,220,244,261],"administration":[43],"China":[45,121,160,235],"and":[46,66,77,98,122,137,161,181,236,259],"United":[48,126,165,240],"States":[49],"was":[50,71,196,251],"conducted":[51],"present":[54],"study.":[55],"Markov":[56],"models":[57],"were":[58,128,171],"established":[59],"based":[60],"on":[61],"data":[62],"from":[63],"FLAURA":[65],"AURA3":[67],"trials.":[68],"First-line":[69,219],"compared":[72,184,254],"both":[74],"first-generation":[75,84,143,257],"EGFR-TKIs":[76,258],"second-line":[78,175,260],"after":[80],"failure":[82],"EGFR-TKIs.":[85],"The":[86,130,146,207],"also":[88],"considered":[89],"payment":[91],"modalities":[92],"available":[93],"China.":[95,274],"Additionally,":[96],"one-way":[97,208],"probability":[99],"sensitivity":[100,209],"analyses,":[101],"willingness-to-pay":[104],"threshold":[105],"(WTP)":[106],"three":[108],"times":[109],"per":[111],"capita":[112],"gross":[113],"domestic":[114],"product":[115],"[$27,783/quality-adjusted":[116],"life":[117],"year":[118],"(QALY)":[119],"for":[120,124],"$100,000/QALY":[123],"States],":[127],"performed.":[129],"first-line":[131,189,243,256],"group":[133,150],"displayed":[134,151],"higher":[135,179,226],"QALYs":[136,180],"costs":[138,183],"than":[139],"those":[140,186],"EGFR-TKI":[144,149],"group.":[145,191],"first":[147],"generation":[148],"an":[152,202],"incremental":[153],"ratio":[155],"(ICER)":[156],"$212,252/QALY":[158],"$151,922/QALY":[162],"States.":[166,241],"In":[167],"addition,":[168],"ICERs":[170],"negative":[172],"group,":[177],"lower":[182],"Furthermore,":[192],"company":[194,266],"donation":[195,267],"benefit":[198],"China,":[200],"average":[203],"$836/QALY.":[206],"highlighted":[211],"influence":[213],"utilities":[215],"states.":[218],"could":[221,246],"be":[222,269],"cost-effective":[223,253],"either":[224],"WTP":[227],"or":[228],"price":[230],"reduction":[231],"68%":[233],"9%":[237],"Although":[242],"therapy":[245],"have":[247],"health":[248],"benefits,":[249],"it":[250],"not":[252],"therapy.":[262],"paying":[264],"via":[265],"may":[268],"good":[271],"choice":[272]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":4},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2021-08-16T00:00:00"}